You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 3, September 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Infectious Mononucleosis With Fatal Neuronitis

J. CLAYTON DAVIE, MD; R. CEBALLOS, MD; S. C. LITTLE, MD

Arch Neurol. 1963;9(3):265-272.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The syndrome of ascending paralysis was described by Landry1 in 1859, and the first report of what is now termed infectious mononucleosis was made by Pfeiffer2 in 1889. In 1916 Guillain, Barré, and Strohl3 reported that facial diplegia and a dispro-portionate increase in the cerebrospinal fluid protein might occur in Landry's paralysis. Since 1927 when Draganesco and Claudian4 first referred to this as the "Guillain-Barré" syndrome, this term has come into wide us-age. As Guillain himself5 later stated that such cases could occur without the "albuminocytologic dissociation," and as it has been repeatedly reported that otherwise identical cases occur without facial diplegia, the term "Guillain-Barré" syndrome seems to have little special merit. Many other terms have been applied to the same condition, including the name "neuronitis."

In 1931 Johansen6 and also Epstein and Dameshek7 reported that the nervous system might be involved . . . [Full Text PDF of this Article]


Author Affiliations

BETHESDA, MD; INGATON, ONT, CANADA; BIRMINGHAM


Footnotes

Submitted for publication June 5, 1963; accepted June 8.

National Institute of Neurological Diseases and Blindness, National Institutes of Health (Dr. Davie); Neuropathologist, Hotel Dieu Hospital (Dr. Ceballos); Chief, Division of Neurology, Medical College of Alabama (Dr. Little).

This study was supported in part by US Public Health Service grant 2B 5081, National Institute of Neurological Diseases and Blindness.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.